Support info of Safety of thoracic radiotherapy followed by PD-1/PD-L1 inhibitor after induction therapy for extensive-stage small cell lung cancer

中华放射肿瘤学杂志


	2022, Vol. 31(3): 236-241 DOI: 10.3760/cma.j.cn113030-20211014-00407

	Safety of thoracic radiotherapy followed by PD-1/PD-L1 inhibitor after induction therapy for extensive-stage small cell lung cancer
	Liu Wenyang¹, Han Ziming¹, Wang Jianyang¹, Zhang Tao¹, Chen Dongfu¹, Feng Qinfu¹, Xiao Zefen¹, Lyu Jima¹, Wang Xin¹, Deng Lei¹, Wang Wenqing¹, Zhai Yirui¹, Wang Zhijie², Wang Jie², Bi Nan¹, Zhou Zongmei¹
	¹Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; ²Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
	Received 2021-10-14 Revised null
	Supporting info